Clinical features, outcome and cost of hyponatremia-associated admission and hospitalization in elderly and very elderly patients: a single-center experience in Turkey

Int Urol Nephrol. 2013 Feb;45(1):265-73. doi: 10.1007/s11255-012-0307-9. Epub 2012 Oct 11.

Abstract

Purpose: Hyponatremia is a common electrolyte disorder in hospitalized patients. Clinical features, outcome and cost of hyponatremia-associated admission and hospitalization in elderly and very elderly patients are not well known.

Methods: Elderly (>64 years) patients admitted to the emergency department (ED) and hospitalized between January 1, 2010, and December 31, 2010, were evaluated. Hyponatremia was defined as serum sodium level below 135 mmol/L. Hyponatremic patients were divided into two groups: group 1 (n = 150, 65-74 years old) and group 2 (n = 103, >74 years old).

Results: A total of 4,960 patients above 65 years of age admitted to ED and hospitalized were included. Prevalence of ED in group 1 and group 2 was 4.1 % (150/3,651) and 7.8 % (103/1,309), respectively (p < 0.001). Vomiting and diarrhea were the most important complaints. A total of 111 (43.8 %) patients were being treated with renin-angiotensin system (RAS) blockers. Mortality, morbidity and hospital cost increased in parallel to decrease in serum Na(+) level and increase in age. Group 2 subjects had not only higher intensive care need (p < 0.01) and mortality rates (p < 0.01), but also higher hospital cost burden (p < 0.05) compared to group 1. Alzheimer's disease was one of the most common co-morbidity in patients, particularly in group 2 (5.3 % vs. 21.3 %, p < 0.001).

Conclusion: Hyponatremia-associated hospitalization is an important and potentially lethal condition in elderly and very elderly patients. Clinicians should be careful when prescribing RAS blockers and diuretics in elderly patients.

MeSH terms

  • Acute Kidney Injury / epidemiology
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Analysis of Variance
  • Angiotensin Receptor Antagonists / adverse effects
  • Angiotensin-Converting Enzyme Inhibitors / adverse effects
  • Bacteremia / epidemiology
  • Critical Care / statistics & numerical data
  • Diarrhea / complications
  • Emergency Service, Hospital / statistics & numerical data
  • Hospital Costs / statistics & numerical data*
  • Humans
  • Hyponatremia / economics
  • Hyponatremia / etiology*
  • Hyponatremia / mortality*
  • Length of Stay / economics
  • Length of Stay / statistics & numerical data
  • Prevalence
  • Retrospective Studies
  • Severity of Illness Index
  • Sodium / blood
  • Sodium Chloride Symporter Inhibitors / adverse effects
  • Statistics, Nonparametric
  • Time Factors
  • Turkey / epidemiology
  • Vomiting / complications

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Sodium Chloride Symporter Inhibitors
  • Sodium